Moving from a really diversified health care conglomerate to a pure-play company, along the way creating really out of one company, four excellent companies, Haleon ... the first win this year ...

And Gentrack is really well placed to continue to win share from these legacy incumbents ... and Livewire's James Marlay Zoe Middleton: One stock that you could hold in almost any environment would be ...

Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.

RICHMOND, Va. — Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced Monday its plan to upgrade its Richmond research and development facility.

In an interview with Gulf Business, Charles Leslie, global business lead for the Pain Portfolio & Systemics at Haleon ... how we view health and wellness. One of the most noticeable trends ...

Haleon, a global consumer health company, is investing $54.2 million to upgrade its research & development (R&D) facility in Richmond, Virginia. The modernization will enable the company to expand ...

Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

Consumer health giant Haleon has appointed Jo Cooper as its new general manager for the UK & Ireland. Cooper brings 10 years’ experience in senior leadership positions across sales and commercial ...